TYP Price sensitive 18 Nov 2025, 8:55 AM

BED trial accelerates - enrolment grows, dosing in two weeks

Tryptamine Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in